The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Structure−Activity Relationships for a Large Diverse Set of Natural, Synthetic, and Environmental Estrogens
Abstract
Understanding structural requirements for a chemical to exhibit estrogen receptor (ER) binding has been important in various fields. This knowledge has been directly and indirectly applied to design drugs for human estrogen replacement therapy, and to identify estrogenic endocrine disruptors. This paper reports structure-activity relationships (SARs) based on a total of 230 chemicals, including both natural and xenoestrogens. Activities were generated using a validated ER competitive binding assay, which covers a 10(6)-fold range. This study is focused on identification of structural commonalities among diverse ER ligands. It provides an overall picture of how xenoestrogens structurally resemble endogenous 17beta-estradiol (E(2)) and the synthetic estrogen diethylstilbestrol (DES). On the basis of SAR analysis, five distinguishing criteria were found to be essential for xenoestrogen activity, using E(2) as a template: (1) H-bonding ability of the phenolic ring mimicking the 3-OH, (2) H-bond donor mimicking the17beta-OH and O-O distance between 3- and 17beta-OH, (3) precise steric hydrophobic centers mimicking steric 7alpha- and 11beta-substituents, (4) hydrophobicity, and (5) a ring structure. The 3-position H-bonding ability of phenols is a significant requirement for ER binding. This contributes as both a H-bond donor and acceptor, although predominantly as a donor. However, the 17beta-OH contributes as a H-bond donor only. The precise space (the size and orientation) of steric hydrophobic bulk groups is as important as a 17beta-OH. Where a direct comparison can be made, strong estrogens tend to be more hydrophobic. A rigid ring structure favors ER binding. The knowledge derived from this study is rationalized into a set of hierarchical rules that will be useful in guidance for identification of potential estrogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355
Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,729
Kavlock, R. J., Daston, G. P., DeRosa, C., Fenner-Crisp, P., Gray, L. E., Kaattari, S., Lucier, G., Luster, M., Mac, M. J., Maczka, C., et al. (1996) · Environmental Health Perspectives · doi:10.1289/ehp.96104s4715 · Cited by 1,149
Self-citationPike, A. C. W. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4608 · Cited by 986
Atom/Fragment Contribution Method for Estimating Octanol–Water Partition Coefficients
Meylan, W. M., & Howard, P. H. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840120 · Cited by 860
Blair, R. M. (2000) · Toxicological Sciences · doi:10.1093/toxsci/54.1.138 · Cited by 806
Self-citationCrystallographic comparison of the estrogen and progesterone receptor’s ligand binding domains
Tanenbaum, D. M., Wang, Y., Williams, S. P., & Sigler, P. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5998 · Cited by 738
Anstead, G. M., Carlson, K. E., & Katzenellenbogen, J. A. (1997) · Steroids · doi:10.1016/s0039-128x(96)00242-5 · Cited by 627
Structural Features of Alkylphenolic Chemicals Associated with Estrogenic Activity
Routledge, E. J., & Sumpter, J. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3280 · Cited by 493
Korach, K. S., Sarver, P., Chae, K., McLachlan, J. A., & McKinney, J. D. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13092-7 · Cited by 425
Estrogenic Activities of 517 Chemicals by Yeast Two-Hybrid Assay.
Nishihara, T., Nishikawa, J.-I., Kanayama, T., Dakeyama, F., Saito, K., Imagawa, M., Takatori, S., Kitagawa, Y., Hori, S., & Utsumi, H. (2000) · Journal of Health Science · doi:10.1248/jhs.46.282 · Cited by 405
Miksicek, R. J. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90005-1 · Cited by 380
QSAR Models Using a Large Diverse Set of Estrogens
Shi, L. M., Fang, H., Tong, W., Wu, J., Perkins, R., Blair, R. M., Branham, W. S., Dial, S. L., Moland, C. L., & Sheehan, D. M. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000066d · Cited by 363
Self-citationEstrogenic Flavonoids: Structural Requirements for Biological Activity
Miksicek, R. J. (1995) · Experimental Biology and Medicine · doi:10.3181/00379727-208-43830 · Cited by 336
Quantitative comparisons of in vitro assays for estrogenic activities.
Fang, H., Tong, W., Perkins, R., Soto, A. M., Prechtl, N. V., & Sheehan, D. M. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108723 · Cited by 277
Self-citationPerez, P., Pulgar, R., Olea-Serrano, F., Villalobos, M., Rivas, A., Metzler, M., Pedraza, V, & Olea, N. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.98106167 · Cited by 254
Molecular structure in relation to oestrogenic activity. Compounds without a phenanthrene nucleus
Dodds, E. C., & Lawson, W. (1938) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1938.0023 · Cited by 240
Ligand-Based Identification of Environmental Estrogens
Waller, C. L., Oprea, T. I., Chae, K., Park, H.-K., Korach, K. S., Laws, S. C., Wiese, T. E., Kelce, W. R., & Gray, L. E. (1996) · Chemical Research in Toxicology · doi:10.1021/tx960054f · Cited by 203
Tong, W., Lowis, D. R., Perkins, R., Chen, Y., Welsh, W. J., Goddette, D. W., Heritage, T. W., & Sheehan, D. M. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci980008g · Cited by 202
Self-citationGrese, T. A., Cho, S., Finley, D. R., Godfrey, A. G., Jones, C. D., Lugar, C. W., Martin, M. J., Matsumoto, K., Pennington, L. D., Winter, M. A., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9606352 · Cited by 176
Identification and assessment of endocrine disruptors: limitations of in vivo and in vitro assays.
Zacharewski, T. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.98106577 · Cited by 163
Structure-Activity Relationships of Estrogens
Jordan, V. C., Mittal, S., Gosden, B., Koch, R. J., & Lieberman, M. E. (1985) · Environmental Health Perspectives · doi:10.1289/ehp.856197 · Cited by 134
QSAR Models for Binding of Estrogenic Compounds to Estrogen Receptor α and β Subtypes
Tong, W., Perkins, R., Xing, L., Welsh, W. J., & Sheehan, D. M. (1997) · Endocrinology · doi:10.1210/endo.138.9.5487 · Cited by 127
Self-citationAnstead, G. M., Wilson, S. R., & Katzenellenbogen, J. A. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00129a024 · Cited by 123
New biospecific adsorbents for the purification of estradiol receptor.
Bucourt, R., Vignau, M., & TORELLI, V. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34385-5 · Cited by 121
Binding Characteristics of Dialkyl Phthalates for the Estrogen Receptor
Nakai, M., Tabira, Y., Asai, D., Yakabe, Y., Shimyozu, T., Noguchi, M., Takatsuki, M., & Shimohigashi, Y. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9928 · Cited by 119
Commentary: The Structural Pervasiveness of Estrogenic Activity
Katzenellenbogen, J. A. (1995) · Environmental Health Perspectives · doi:10.1289/ehp.95103s799 · Cited by 90
Waller, C. L., Minor, D. L., & McKinney, J. D. (1995) · Environmental Health Perspectives · doi:10.1289/ehp.95103702 · Cited by 89
Tong, W., Perkins, R., Strelitz, R., Collantes, E. R., Keenan, S., Welsh, W. J., Branham, W. S., & Sheehan, D. M. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.971051116 · Cited by 80
Self-citationGantchev, T. G., Ali, H., & van Lier, J. E. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00050a013 · Cited by 78
Wiese, T. E., Polin, L., Palomino, E., & Brooks, S. C. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9703294 · Cited by 66
A Testing Deadline for Endocrine Disrupters
Patlak, M. (1996) · Environmental Science & Technology · doi:10.1021/es962527a · Cited by 53
Sadler, B. R., Cho, S. J., Ishaq, K. S., Chae, K., & Korach, K. S. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9705521 · Cited by 52
Structure-activity relationships of oral organosiloxanes on the male reproductive system
Bennett, D. R., Gorzinski, S. J., & LeBeau, J. E. (1972) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(72)90027-0 · Cited by 39
Cited by
Benchmarking sets for molecular docking.
Huang, N., Shoichet, B. K., & Irwin, J. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0608356 · Cited by 1,318
Concentrations of parabens in human breast tumours
Darbre, P. D., Aljarrah, A., Miller, W. R., Coldham, N. G., Sauer, M. J., & Pope, G. S. (2004) · Journal of Applied Toxicology · doi:10.1002/jat.958 · Cited by 805
Sharma, J., Mishra, I. M., Dionysiou, D. D., & Kumar, V. (2015) · Chemical Engineering Journal · doi:10.1016/j.cej.2015.04.021 · Cited by 625
Isoflavones: estrogenic activity, biological effect and bioavailability
Vitale, D. C., Piazza, C., Melilli, B., Drago, F., & Salomone, S. (2013) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-012-0112-y · Cited by 490
Equol, a natural estrogenic metabolite from soy isoflavones
Muthyala, R. S., Ju, Y. H., Sheng, S., Williams, L. D., Doerge, D. R., Katzenellenbogen, B. S., Helferich, W. G., & Katzenellenbogen, J. A. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.11.035 · Cited by 438
Metadata
- Authors
- Fang, H., Tong, W., Shi, L. M., Blair, R., Perkins, R., Branham, W., Hass, B. S., Xie, Q., Dial, S. L., Moland, C. L., & Sheehan, D. M.
- Venue
- Chemical Research in Toxicology
- Publisher
- American Chemical Society (ACS)
- Published
- 2001-02-10
- Volume
- 14
- Issue
- 3
- Pages
- 280-294
- ISSN
- 0893-228X (ISSN-L)
- 1520-5010
- OpenAlex
- W2055878543
- Cited by
- 449
- References
- 34
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.